Oramed Pharmaceuticals Inc (XTAE:ORMP)
₪ 9.425 -0.058 (-0.61%) Market Cap: 369.60 Mil Enterprise Value: -200.76 Mil PE Ratio: 4.89 PB Ratio: 0.58 GF Score: 32/100

Oramed Pharmaceuticals Inc at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript

Dec 07, 2022 / 06:30PM GMT
Release Date Price: ₪28.4 (+0.42%)
Robert Kraft
Planet MicroCap - Moderator

Welcome to the Planet MicroCap Showcase Virtual 2022. I'm your host, Robert Kraft, and thank you all for joining us. Now presenting is Nadav Kidron, Chairman and CEO of Oramed. It's a publicly traded company. The symbol is ORMP on NASDAQ. And with that Nadav, take it away.

Nadav Kidron
Oramed Pharmaceuticals Inc - CEO, President, & Director

Thank you, Robert. Thank you for the introduction. It's a real pleasure to be here today. It's our first time being in this conference. So we are very excited to be here and as it's the first time, I'm sure many of you have not heard our story, so we are excited to share our story with you.

So Oramed in a snapshot, so Oramed has got a platform technology that allows us to take injection and deliver them orally. The company is now probably in a most exciting time since we were created in 2006. We have a very strong financial position of $160 million in cash. There's no debt and there's a lot of interesting things that are coming up our way and we're looking forward to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot